Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 19 of 19 for “"IDH mutations"”.
-
Epigenetic Basis for the Oncogenic Potential of IDH Mutations
… identified as the product of cancer-associated mutations in isocitrate dehydrogenases (IDH). To determine whether metabolic perturbation can disrupt chromatin remodeling and transcription, I investigated the epigenetic consequences of 2HG-producing IDH mutations. In this thesis, 2HG was …
-
Integrating DNA Methylation and 3D-genome Architecture to Identify Functional Regulatory Sequences in IDH-mutant AML
… phenotypically heterogeneous disease. Recurrent mutations in genes involved in epigenetic pathways are common in AML and are thought to contribute to this variability by disrupting epigenetic patterns relative to normal hematopoietic cells. The most well-studied epigenetic modification in AML is …
-
Impact of IDH1 and IDH2 Mutation Detection at Diagnosis and in Remission in Acute Myeloid Leukemia Patients Receiving Allogeneic Transplantation
… in the isocitrate dehydrogenase 1 or 2 gene (IDH1 and IDH2). Therefore, these mutations are among the common ones in AML. However, the prognostic significance of mutated IDH in AML patients remains controversial. Several research groups reported distinct outcomes within specific patient …
-
Characterization of the effects of IDH2 mutations and (R)-2-HG in cancer progression
The isocitrate dehydrogenase (IDH) family of enzymes is central to cellular metabolism, catalyzing the oxidative decarboxylation of isocitrate to α-ketoglutarate (α-KG) and production of NADPH. Recently, cancer-associated heterozygous somatic mutations in family members IDH1 and IDH2 were …
-
Epigenetic regulation in normal hematopoiesis and its dysfunction in leukemia
… content of neomorphic isocitrate dehydrogenase (IDH) mutations. Comparison of the methylation landscape in the AML cells with and without IDH mutations revealed a higher fractional DNA methylation level at active enhancers in the IDH mutant cells. However, there was no significant difference in …
-
Characterizing Metabolomic Activity in Mutant IDH Chondrosarcomas Chondrocytes
… of cartilage and are associated with somatic mutations in isocitrate dehydrogenase 1 (IDH1) and IDH2 genes. IDH mutations have also been identified in its benign precursor lesion, enchondromas; thus, suggesting that IDH mutations are early events in malignant chondrosarcoma transformation. …
-
Μεταλλάξεις γονιδίων στην οξεία μυελογενή λευχαιμία, συσχέτιση με τους ισχύοντες προγνωστικούς παράγοντες στα ποσοστά ύφεσης, υποτροπής, ολικής επιβίωσης
… the contributionof at least two classes of mutations to evolve to full-blown leukemia.Various mutations have been identified that alter the switching signal and enhance the proliferation of leukemic cells and their survival. These include mutations in the FLT3, RAS and KIT …
-
Vitamin C induced epigenomic remodelling in IDH1 mutant acute myeloid leukemia
… abnormalities. Heterozygous, inactivating TET2 mutations and neomorphic IDH mutations are recurrent and mutually exclusive in acute myeloid leukemia genomes. Ascorbic Acid (vitamin C) has been shown to stimulate the catalytic activity of TET2 in vitro and thus we sought to explore its effect in …
-
A review on diffuse glioma and gene transfer technologies and the impact of COVID-19 on neurosurgical oncology service provision
… It is now increasingly recognised that IDH mutations are linked to the development of glioma and tumour reoccurrence. IDH mutations can lead to genetic and epigenetic changes promoting cell proliferation, tumour invasion and immune evasion as well as preventing differentiation. …
-
Atrx Inactivation and Idh1-R132H Drive Preferential Sensitivity to Proton Vs. X-Ray Radiotherapy In Glioma Stem Cells
… previous studies have individually linked IDH mutations, specifically IDH1R132H, and ATRX inactivating mutations to improved patient outcomes and suppressed DNA damage repair compared to their respective wild-types, the mechanisms by which these two genetic alterations interact in GSCs …
-
DNA methylation & its regulation in colorectal tumours
… de-methylation, with pathogenic loss-of-function mutations thought to drive a hyper-methylated phenotype in acute myeloid leukaemia (AML). Similarly, pathogenic mutations in isocitrate dehydrogenase (IDH) 1 and 2 have also been reported in AML and present with a similar hyper-methylated phenotype. …
-
CROSSTALK BETWEEN GLIOMA CELLS AND TUMOR ASSOCIATED-MACROPHAGES: MECHANISMS AND THERAPEUTIC STRATEGIES
… the resistance to immunomodulating treatments. Mutations in enzymes isocitrate dehydrogenases (IDH) occur in GBM subsets, characterized by more favorable prognosis. Also, other molecular alterations and metabolic features, such as accumulation of the oncometabolite 2-hydroxyglutarate, are …
-
Μελέτη των μηχανικών ιδιοτήτων των γλοιωμάτων εγκεφάλου σε χειρουργικά ιστοτεμάχια
… like isocitrate dehydrogenase gene family (IDH) mutations and WHO grade, age and preconditioning on tumor and peritumoral white matter elasticity was assessed using linear mixed-effects models. Results: The elastic modulus did not differ significantly between the glioma tissue and the …
-
Genomic approaches to guide the molecular classification of glioma
… number of large-scale genomic studies identified mutations in the TERT promoter and IDH1/2 in ~80% of all gliomas. Based on the occurrence of these mutations, gliomas can be classified into objective molecular subtypes that stratify patients into clear prognostic subgroups more effectively than by …
-
The prognostic value of biomarkers in the evaluation of glioblastoma multiforme
… used for the assessment of GBM include the IDH mutations, MGMT methylation status, and EGFRvIII. Furthermore, this review will offer a perspective on experimental approaches currently under investigation for treatment of GBM. LITERATURE REVIEW FINDINGS: MGMT methylation of the promoter …
-
Mechanistic and functional insights into the recognition and regulation of DNA modifications by UHRF1, DNMT1 and TET proteins
… of 2-HG, an oncometabolite produced by mutant IDH enzymes, is also examined in mESCs, offering the possibility to precisely study the basis of epigenetic alterations observed in tumors harboring IDH mutations. Lastly, this thesis includes the examination of cross-regulating functions of TET1 …
-
Developing liquid chromatography-mass spectrometry strategies for investigating energy metabolism with application to isocitrate dehydrogenase mutations in cancer
Isocitrate dehydrogenases (IDHs) act in the tricarboxylic acid (TCA) cycle to catalyse the conversion of isocitrate to 2-oxoglutarate (2-OG) with concomitant production of NADH and/or NADPH. In humans, mutations causing IDH1 and IDH2 substitutions have been found during DNA sequencing of human …
-
Deciphering key roles of WNT6 in glioblastoma: mechanistic, functional, and clinical insights
… to lower-grade gliomas, independently of IDH mutations and 1p/19q co-deletion status, and in a gene-dosage independent manner. Moreover, WNT6 expression was associated with increased GBM cell viability, proliferation, invasion, migration, glioma stem cell capacity, and resistance to …
-
The contribution of meta-analytical methodology to the investigation of primary central nervous system tumors
… were reported. Among molecular aberrations, IDH mutation and MGMT promoter methylation were the most commonly reported. Median overall and progression-free survival were 13 and 10 months, with 5-year rates of 18% and 13%, respectively. Age ≥65 years at diagnosis, high-grade tumor, type II …